Wasp Venom (Ves v 5) IgE Test · Blood

If you have had a serious reaction to an insect sting, the single most useful question is: which bug actually caused it? Standard venom allergy testing often returns ambiguous results, showing positivity to both bee and wasp even when only one is the true culprit. This test zeroes in on a wasp-specific protein to help answer that question with more precision.

Ves v 5 (also called antigen 5) is a major protein found only in wasp venom, not in honeybee venom. Measuring IgE antibodies against this specific protein in your blood helps confirm a true wasp allergy, sort out confusing dual-positive results, and guide whether venom immunotherapy is appropriate.

What This Test Actually Measures

The test detects IgE (immunoglobulin E) antibodies in your blood that specifically bind to the Ves v 5 protein from common wasp (Vespula) venom. IgE is the antibody class your immune system produces when it has been sensitized to an allergen. The presence of IgE against Ves v 5 means your immune system recognizes wasp venom as a threat and is primed to launch an allergic response on exposure.

Ves v 5 is a small protein produced by the venom glands of wasps. The test uses a recombinant (lab-made) version of this protein to detect antibodies with high precision. Because Ves v 5 does not exist in honeybee venom, a positive result is a strong indicator of wasp-specific sensitization rather than cross-reactivity from other insects.

Why The Culprit Insect Matters

When someone reacts to a sting, basic blood tests often show positivity to both bee and wasp venom. Much of this double positivity is not true dual allergy. It is caused by shared sugar structures on the venom proteins called cross-reactive carbohydrate determinants (CCDs), which can fool standard tests.

Ves v 5 is a marker allergen. It is species-specific to wasps. Combining Ves v 5 IgE with a bee-specific marker (Api m 1) lets you tell whether someone is truly allergic to one venom, the other, or both. This matters because venom immunotherapy uses the actual venom, and treating with the wrong one offers no protection.

How Well The Test Performs

In people with confirmed wasp allergy, IgE to recombinant Ves v 5 is detected in roughly 87 to 94 percent of cases across multiple cohorts. Sensitivity rises even higher when paired with Ves v 1, another wasp venom component. Specificity is also strong, with essentially no Ves v 5 IgE found in people who are allergic only to bees.

Sources: Müller et al. 2012 Allergy; Mittermann et al. 2010 J Allergy Clin Immunol; Šelb et al. 2016 Clin Exp Allergy.

What this means for you: a positive Ves v 5 IgE result is informative for confirming wasp sensitization, but the number itself cannot tell you how dangerous a future sting might be. Clinical history of past reactions, baseline tryptase levels, and other risk factors carry more weight in predicting severity.

What Your Result Reveals About Risk

A positive Ves v 5 IgE result strongly supports wasp venom sensitization. It is the foundation for deciding whether venom immunotherapy makes sense, and which venom to use. In ambiguous double-positive cases, it can prevent unnecessary dual therapy when only one venom is the real driver.

A negative or very low result generally argues against wasp sensitization, but it does not fully exclude risk in everyone. Some patients with severe anaphylaxis show low Ves v 5 IgE, particularly those with elevated baseline tryptase or underlying mast cell disorders. In these higher-risk groups, lower assay cutoffs or additional components like Ves v 1 may be needed to detect sensitization that would otherwise be missed.

Why The Number Alone Does Not Predict Severity

This is the most counterintuitive finding in the research, and it deserves a direct explanation. Across multiple cohorts, the absolute level of Ves v 5 IgE does not reliably correlate with how severe a sting reaction will be. People with modest IgE levels have experienced full anaphylaxis, and people with high IgE levels have had relatively mild reactions.

Here is the framework that reconciles this: Ves v 5 IgE is best understood as a yes-or-no marker of sensitization, not a dial of danger. It tells you whether your immune system has been primed to wasp venom. How loudly that primed system actually fires when stung depends on additional variables, including baseline tryptase (a mast cell marker), age, presence of mast cell disorders, latency between sting and symptom onset, and whether skin symptoms appear. These risk factors, combined with your sting history, do more to predict severity than the IgE titer itself.

Tracking Your Trend Over Time

For most allergy markers, a single reading captures a snapshot. Ves v 5 IgE is more useful when tracked, particularly if you are undergoing venom immunotherapy or considering whether to continue it. During successful treatment, Ves v 5 IgE generally declines while a blocking antibody class called IgG4 rises, helping to suppress allergic reactivity.

A practical cadence: get a baseline before starting immunotherapy, then retest annually during treatment to confirm the expected trajectory. After stopping therapy, IgG4 blocking capacity wanes over several years, so periodic retesting can help judge whether protection is holding. If you have never had immunotherapy but had a sting reaction, a single test confirms sensitization; retesting becomes useful if your clinical picture changes or you are stung again.

When Results Can Be Misleading

A few situations can distort interpretation of a single Ves v 5 IgE reading:

• Recent sting: after a controlled or accidental sting, venom-specific IgE can drop slightly within the first few hours, then rise substantially over the following weeks. Testing too soon after a sting may not reflect your stable baseline.
• Cross-reactive carbohydrate determinants on whole-venom panels: if you only have a standard extract-based venom panel, dual positivity to bee and wasp may simply reflect shared sugar structures, not true dual allergy. Ves v 5 component testing is what cuts through that ambiguity.
• Elevated tryptase or mast cell disorders: patients in these higher-risk categories may have lower Ves v 5 IgE than expected. A standard cutoff may miss sensitization in these individuals.
• Time after stopping immunotherapy: Ves v 5 IgE and protective IgG4 both shift over months to years after therapy ends, so a result taken at one timepoint may not represent long-term status.

What To Do With An Out-Of-Pattern Result

If your Ves v 5 IgE comes back positive and you have a history of a systemic reaction to a sting, the next step is consultation with an allergist or immunologist for venom immunotherapy planning. Companion tests usually include IgE to Api m 1 (the major bee venom marker), Ves v 1 (wasp phospholipase), and baseline serum tryptase. Together these clarify the culprit insect, refine treatment selection, and flag higher-risk profiles.

If your result is negative but you had a clear systemic reaction after a sting, do not assume you are in the clear. Ask about additional component testing, basophil activation testing, or repeat measurement, especially if your tryptase is elevated. If your result is positive but you have never had a systemic reaction, the finding is best interpreted with caution. Sensitization is common in the general population and in highly exposed groups like hunters and fishers, and most sensitized people never have severe reactions. Discuss your individual context with a specialist before drawing conclusions.